Fulton Breakefield Broenniman’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Sell |
40,489
-143
| -0.4% | -$111K | 2.13% | 15 |
|
|
2025
Q1 | $33.6M | Sell |
40,632
-2,008
| -5% | -$1.66M | 2.42% | 12 |
|
|
2024
Q4 | $32.9M | Sell |
42,640
-75
| -0.2% | -$57.9K | 2.35% | 11 |
|
|
2024
Q3 | $37.8M | Sell |
42,715
-965
| -2% | -$855K | 2.64% | 11 |
|
|
2024
Q2 | $39.5M | Sell |
43,680
-248
| -0.6% | -$225K | 2.92% | 7 |
|
|
2024
Q1 | $34.2M | Sell |
43,928
-12,056
| -22% | -$9.38M | 2.63% | 10 |
|
|
2023
Q4 | $32.6M | Sell |
55,984
-653
| -1% | -$381K | 2.63% | 10 |
|
|
2023
Q3 | $30.4M | Sell |
56,637
-806
| -1% | -$433K | 2.64% | 9 |
|
|
2023
Q2 | $26.9M | Sell |
57,443
-11,233
| -16% | -$5.27M | 2.23% | 12 |
|
|
2023
Q1 | $23.6M | Sell |
68,676
-1,055
| -2% | -$362K | 2.03% | 13 |
|
|
2022
Q4 | $25.5M | Buy |
69,731
+112
| +0.2% | +$41K | 2.26% | 11 |
|
|
2022
Q3 | $22.5M | Sell |
69,619
-10,748
| -13% | -$3.48M | 2.11% | 13 |
|
|
2022
Q2 | $26.1M | Sell |
80,367
-8,476
| -10% | -$2.75M | 2.25% | 9 |
|
|
2022
Q1 | $25.4M | Buy |
88,843
+1,185
| +1% | +$339K | 2.24% | 12 |
|
|
2021
Q4 | $24.2M | Buy |
87,658
+1,455
| +2% | +$402K | 1.79% | 18 |
|
|
2021
Q3 | $19.9M | Sell |
86,203
-551
| -0.6% | -$127K | 1.71% | 21 |
|
|
2021
Q2 | $19.9M | Sell |
86,754
-41,242
| -32% | -$9.47M | 1.7% | 23 |
|
|
2021
Q1 | $23.9M | Buy |
127,996
+22,721
| +22% | +$4.24M | 2.21% | 12 |
|
|
2020
Q4 | $17.8M | Sell |
105,275
-15,425
| -13% | -$2.6M | 2.13% | 13 |
|
|
2020
Q3 | $17.9M | Buy |
120,700
+24,443
| +25% | +$3.62M | 2.01% | 19 |
|
|
2020
Q2 | $15.8M | Buy |
96,257
+3,750
| +4% | +$616K | 1.92% | 21 |
|
|
2020
Q1 | $12.8M | Buy |
92,507
+3,029
| +3% | +$420K | 1.92% | 20 |
|
|
2019
Q4 | $11.8M | Buy |
89,478
+1,055
| +1% | +$139K | 1.37% | 31 |
|
|
2019
Q3 | $9.89M | Buy |
+88,423
| New | +$9.89M | 1.26% | 42 |
|